Date Filed | Type | Description |
02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2020 |
SC 13G
| VENROCK ASSOCIATES V LP reports a 32.6% stake in Cloudflare, Inc. |
10/08/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
08/02/2018 |
SC 13G
| VENROCK ASSOCIATES V LP reports a 6.8% stake in Constellation Pharmaceuticals, Inc. |
02/13/2018 |
SC 13G/A
| VENROCK ASSOCIATES V LP reports a 4.7% stake in FATE THERAPEUTICS, INC. |
11/20/2015 |
SC 13D
| VENROCK ASSOCIATES V LP reports a 30.3% stake in CASTLIGHT HEALTH, INC. |
11/04/2015 |
SC 13D/A
| VENROCK ASSOCIATES V LP reports a 4.5% stake in ZELTIQ AESTHETICS, INC. |
02/13/2015 |
SC 13G
| VENROCK ASSOCIATES V LP reports a 33.6% stake in CASTLIGHT HEALTH, INC. |
02/20/2014 |
SC 13D/A
| VENROCK ASSOCIATES V LP reports a 9.5% stake in ZELTIQ AESTHETICS, INC. |
02/14/2014 |
SC 13G
| VENROCK ASSOCIATES V LP reports a 7.3% stake in RECEPTOS, INC. |
11/18/2013 |
SC 13D/A
| VENROCK ASSOCIATES V LP reports a 14.9% stake in ZELTIQ AESTHETICS, INC. |
10/11/2013 |
SC 13G
| VENROCK ASSOCIATES V LP reports a 12.2% stake in FATE THERAPEUTICS, INC. |
03/15/2013 |
SC 13D
| VENROCK ASSOCIATES V LP reports a 16.9% stake in ZELTIQ AESTHETICS, INC. |
02/14/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/26/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
10/30/2008 |
SC 13D
| Form SC 13D -- General statement of acquisition of beneficial ownership |